Energy metabolism of hepatic allografts subjected to prolonged warm ischemia and pharmacologic modulation with FK506 and platelet activating factor antagonist.
Takada
Y
Y
Department of Surgery, Institute of Clinical Medicine, Tsukuba University, Japan.
Fukunaga
K
K
Taniguchi
H
H
Yuzawa
K
K
Otsuka
M
M
Fukao
K
K
D000227:Adenine Nucleotides / Q000378:metabolism*; D000818:Animals; D001219:Aspartate Aminotransferases / Q000097:blood; D004734:Energy Metabolism / Q000187:drug effects; D006085:Graft Survival / Q000187:drug effects / Q000502:physiology*; D007511:Ischemia; D008099:Liver / Q000098:blood supply; D016031:Liver Transplantation / Q000276:immunology / Q000502:physiology*; D009926:Organ Preservation / Q000379:methods*; D010880:Piperidines / Q000494:pharmacology*; D010972:Platelet Activating Factor / Q000037:antagonists & inhibitors*; D011184:Postoperative Period; D011726:Pyridinium Compounds / Q000494:pharmacology*; D013552:Swine; D016559:Tacrolimus / Q000494:pharmacology*; D013696:Temperature; D014184:Transplantation, Homologous
D000227:Adenine Nucleotides; D010880:Piperidines; D010972:Platelet Activating Factor; D011726:Pyridinium Compounds; C072429:E 5880; D001219:Aspartate Aminotransferases; D016559:Tacrolimus